UFP Technologies, Inc. · NASDAQ:UFPT

UFP Technologies — Investor Presentation (August 2026)

14 slides from UFP Technologies's investor presentation, August 2026

  1. Slide 1: Welcome Investors

    Slide 1: Welcome Investors

    Welcome Investors August 2026 1

  2. Slide 2: Forward Looking Statements

    Slide 2: Forward Looking Statements

    Forward Looking Statements Some of the statements contained in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). Management and representat

  3. Slide 3: Investment Overview

    Slide 3: Investment Overview

    Investment Overview UFP Technologies is a trusted contract $603M $2.5B* development and manufacturing organization Revenue (2025) Market Cap specializing in comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. NASDAQ: UFPT | Newburyport, Massac

  4. Slide 4: Attractive Market Opportunity

    Slide 4: Attractive Market Opportunity

    Attractive Market Opportunity Large, growing, regulated, and fragmented with serial innovation ~$518B1 ~$100B2 ~15+ Global Medical Outsourcing Major Market Device Market Opportunity Segments ~6.3% CAGR1 ~10% CAGR2 ~75 Sub-Segments UFP's Core Focus on Plastic Products Growing Segments Single Use Diff

  5. Slide 5: What We Do: Development & Manufacturing Partner, Enabling Better Patient Outcomes

    Slide 5: What We Do: Development & Manufacturing Partner, Enabling Better Patient Outcomes

    What We Do: Development & Manufacturing Partner, Enabling Better Patient Outcomes Developing new innovations into long-term manufacturing revenue Who we serve Large Global OEMs Niche Device Makers Well-Funded Start-Ups What we do Early Development Scale & Optimize Full Production Design, prototyping

  6. Slide 6: What We Do: Turning Product Ideas into Reality with Material Technology

    Slide 6: What We Do: Turning Product Ideas into Reality with Material Technology

    What We Do: Turning Product Ideas into Reality with Material Technology Robotic Drapes Access Port Surgical Site Pacemaker Catheter Sterile Barriers Implants Patient Beds Surgical Screws NPWT Dressing Patient Transfer RAS Patient Beds Cardiovascular Infection Control Orthopedics Wound Care 6 Confide

  7. Slide 7: Differentiation and Competitive Advantage

    Slide 7: Differentiation and Competitive Advantage

    Differentiation and Competitive Advantage Innovate and scale with engineering, material, and manufacturing expertise Durable 1 Design In Early 2 Scale & Optimize 3 Relationships Ability to make technology Experience and trust to High switching costs secures available at the front-end of scale with a

  8. Slide 8: Segment Focus

    Slide 8: Segment Focus

    Segment Focus Exposure to growth medical segments offering differentiated single-use technologies to improve patient outcomes and deliver value ~13-17% ~6% ~6.5-7% Robotic Assisted Surgery CAGR* CAGR* CAGR* Patient Beds & Handling Cardiovascular ~5.5-6.5% ~4-5% ~5-6% CAGR* CAGR* CAGR* Infection Cont

  9. Slide 9: Strategy to Win

    Slide 9: Strategy to Win

    Strategy to Win Disciplined strategy designed to compound revenue and earnings through organic growth and customer-centric acquisitions Customer-Centric M&A Organic Growth 12-18% Onboard partner Blended Differentiated companies to Annual Growth material technologies decentralized in faster-growing T

  10. Slide 10: Proven Financial Performance

    Slide 10: Proven Financial Performance

    Proven Financial Performance Consistent multi-year growth with meaningful margin expansion Revenue ($M) & Adj. Operating Margin 700 600 $504 $603 70% 60% 3.4× 29.0% Gross Margin (YTD 500 50% Revenue growth $400 through June 30, 2020–2025 400 40% 2026) $354 300 30% $206 18.3% 17.2% $179 16.4% 17.1% 2

  11. Slide 11: Clear Financial Framework and Capital Discipline

    Slide 11: Clear Financial Framework and Capital Discipline

    Clear Financial Framework and Capital Discipline Clear financial targets supported by disciplined capital allocation and leverage philosophy 3–5 Year Financial Targets 12–18% 28–31% 17–20% Annual Revenue Gross Adj. Operating Growth Margins Margins 11 Confidential, property of UFP Technologies, Inc.

  12. Slide 12: Experienced Management Team

    Slide 12: Experienced Management Team

    Experienced Management Team Deep MedTech expertise driving decentralized platform execution Mitch Rock Ron Lataille Ryan Stafford Jason Holt President and CEO CFO, SVP & Treasurer General Counsel & SVP HR SVP 33 yrs at UFP 29 yrs at UFP Former EVP LFUS Former ITW, 8 yrs at UFP Marcelo Soliz Daniel L

  13. Slide 13: Why Invest Now?

    Slide 13: Why Invest Now?

    NASDAQ: UFPT investorinfo@ufpt.com www.ufpt.com Why Invest Now? A High-Quality MedTech Platform Built to Compound Value Over Time Large, growing, fragmented market Differentiated technology embedded with customers Driving better patient outcomes and durable growth Experienced team with operating pla

  14. Slide 14: Thank You!

    Slide 14: Thank You!

    UFP TECHNOLOGIES Thank You! 14

Source: company website

More decks from UFP Technologies, Inc.

All 33 UFP Technologies decks